[Corrigendum] Effects of 17-allylamino-17-demethoxygeldanamycin on the induction of apoptosis and cell cycle arrest in HCT-116 cells
Xuerong Zhao, Jianping Wang, Lijun Xiao, Qian Xu, Enhong Zhao, Xin Zheng, Huachuan Zheng, Shuang Zhao, Shi Ding
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer therapeutics and mechanisms · Drug Transport and Resistance Mechanisms · Histone Deacetylase Inhibitors Research
Oncol Lett 14: 2177–2185, 2017; DOI: 10.3892/ol.2017.6442
Following the publication of the above article, an interested reader drew to the authors' attention that, concerning the mRNA electrophoretic blots shown in Fig. 5A on p. 2182, the middle and right-hand blots for Cyclin D1 were similar to the left-hand and middle blots for Caspase 9; in addition, the left-hand Cyclin D1 blot was similar to the right-hand blot for GAPDH in the same figure part.
In response to the reader's enquiry, the authors have submitted a revised version of Fig. 5, now showing alternative data for the Cyclin D1 and GAPDH experiments in Fig. 5A, as presented below. The authors can confirm that any errors associated with this figure did not have a significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of Oncology Letters for allowing them the opportunity to publish this Corrigendum; furthermore, they apologize to the readership of the Journal for any inconvenience caused.